Is levothyroxine being recalled in May 2025? Here's What You Need to Know
•
3 min read
In May 2025, the U.S. Food and Drug Administration (FDA) issued a Class II recall for specific lots of levothyroxine sodium tablets from Accord Healthcare due to subpotency. This was one of several actions taken throughout 2025 concerning thyroid medication manufactured by Intas Pharmaceuticals for Accord Healthcare.
